Myocardial fatty acid metabolism in health and disease
- PMID: 20086077
- DOI: 10.1152/physrev.00015.2009
Myocardial fatty acid metabolism in health and disease
Abstract
There is a constant high demand for energy to sustain the continuous contractile activity of the heart, which is met primarily by the beta-oxidation of long-chain fatty acids. The control of fatty acid beta-oxidation is complex and is aimed at ensuring that the supply and oxidation of the fatty acids is sufficient to meet the energy demands of the heart. The metabolism of fatty acids via beta-oxidation is not regulated in isolation; rather, it occurs in response to alterations in contractile work, the presence of competing substrates (i.e., glucose, lactate, ketones, amino acids), changes in hormonal milieu, and limitations in oxygen supply. Alterations in fatty acid metabolism can contribute to cardiac pathology. For instance, the excessive uptake and beta-oxidation of fatty acids in obesity and diabetes can compromise cardiac function. Furthermore, alterations in fatty acid beta-oxidation both during and after ischemia and in the failing heart can also contribute to cardiac pathology. This paper reviews the regulation of myocardial fatty acid beta-oxidation and how alterations in fatty acid beta-oxidation can contribute to heart disease. The implications of inhibiting fatty acid beta-oxidation as a potential novel therapeutic approach for the treatment of various forms of heart disease are also discussed.
Similar articles
-
Role of fatty acid uptake and fatty acid beta-oxidation in mediating insulin resistance in heart and skeletal muscle.Biochim Biophys Acta. 2010 Jan;1801(1):1-22. doi: 10.1016/j.bbalip.2009.09.014. Epub 2009 Sep 24. Biochim Biophys Acta. 2010. PMID: 19782765 Review.
-
Targets for modulation of fatty acid oxidation in the heart.Curr Opin Investig Drugs. 2004 Mar;5(3):290-4. Curr Opin Investig Drugs. 2004. PMID: 15083595 Review.
-
Acetylation control of cardiac fatty acid β-oxidation and energy metabolism in obesity, diabetes, and heart failure.Biochim Biophys Acta. 2016 Dec;1862(12):2211-2220. doi: 10.1016/j.bbadis.2016.07.020. Epub 2016 Jul 29. Biochim Biophys Acta. 2016. PMID: 27479696 Review.
-
Cardiac Energy Metabolism in Heart Failure.Circ Res. 2021 May 14;128(10):1487-1513. doi: 10.1161/CIRCRESAHA.121.318241. Epub 2021 May 13. Circ Res. 2021. PMID: 33983836 Free PMC article. Review.
-
Cardiac fatty acid oxidation in heart failure associated with obesity and diabetes.Biochim Biophys Acta. 2016 Oct;1861(10):1525-34. doi: 10.1016/j.bbalip.2016.03.020. Epub 2016 Mar 18. Biochim Biophys Acta. 2016. PMID: 26996746 Review.
Cited by
-
Impact of obesity on day-night differences in cardiac metabolism.FASEB J. 2021 Mar;35(3):e21298. doi: 10.1096/fj.202001706RR. FASEB J. 2021. PMID: 33660366 Free PMC article.
-
Relationship between free fatty acids, insulin resistance markers, and oxidized lipoproteins in myocardial infarction and acute left ventricular failure.Diabetes Metab Syndr Obes. 2013;6:103-11. doi: 10.2147/DMSO.S37830. Epub 2013 Feb 18. Diabetes Metab Syndr Obes. 2013. PMID: 23550027 Free PMC article.
-
Neuregulins: protective and reparative growth factors in multiple forms of cardiovascular disease.Clin Sci (Lond). 2020 Oct 16;134(19):2623-2643. doi: 10.1042/CS20200230. Clin Sci (Lond). 2020. PMID: 33063822 Free PMC article. Review.
-
Cardiovascular effects of incretin-based therapies.Rev Diabet Stud. 2011 Fall;8(3):382-91. doi: 10.1900/RDS.2011.8.382. Epub 2011 Nov 10. Rev Diabet Stud. 2011. PMID: 22262075 Free PMC article. Review.
-
Increasing fatty acid oxidation elicits a sex-dependent response in failing mouse hearts.J Mol Cell Cardiol. 2021 Sep;158:1-10. doi: 10.1016/j.yjmcc.2021.05.004. Epub 2021 May 12. J Mol Cell Cardiol. 2021. PMID: 33989657 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous